Sign in
4

Changes in Ownership

PDS Biotechnology Corp Filed Acc 0001127602-19-011939

Chief Financial Officer acquired 82,999 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Saik Andrew Chief Financial Officer 2019-03-15 Option exercise +82,999 82,999 D
Derivatives
Saik Andrew Chief Financial Officer 2019-03-15 Option exercise · Restricted Stock Units −82,999 0 D
Loading xslF345X03/form4.xml…